KSI-301 (Tarcocimab) (Intravitreal Injection)
KSI-301 (Tarcocimab) is an investigational medicine given as an injection into the eye to treat certain retina conditions like Wet Age-related Macular Degeneration (Wet AMD), Diabetic Macular Edema (DME), and Retinal Vein Occlusion (RVO). Drug class Anti-VEGF (Investigational) Type Single Forms Intravitreal Injection Common strength Per dose Prescription status Investigational What KSI-301 (Tarcocimab) is used
